top of page

Strategic Ventures Blog


Strategic Ventures Special Bulletin: Nanocrine Achieves Major Milestone - October 2024
On Wednesday, October 1, 2024, Dr. Patrick Calhoun, President and Chief Science Officer of Nanocrine, Inc., visited the laboratories of the National Cancer Institute (NCI), and tested for the first time Nanocrine’s revolutionary plasmonic chip using living cells.
mhauser994
Oct 22, 20241 min read


Defender: On a Mission to Solve the Global Crisis of Diabetic Foot Ulcers
Spotlight on Defender
Diabetic Foot Ulcers (DFUs) affect approximately 18.6 million people worldwide each year, including 1.6 million new cases every year in the United States alone. DFUs are a recurring, chronic health problem, not just one-time events: over 85% of DFU patients experience a recurrence within 5 years.
mhauser994
Oct 21, 20241 min read


Anyone Can Drown: No One Should
Drowning is the leading cause of death for children ages 1 to 4 in the United States and the second leading cause of death by accidental injury for children 5 to 14.
mhauser994
Sep 6, 20241 min read
bottom of page